Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Notes Payables (2016 - 2025)

Jaguar Health (JAGX) has disclosed Notes Payables for 11 consecutive years, with $27.4 million as the latest value for Q4 2025.

  • Quarterly Notes Payables rose 127.94% to $27.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $27.4 million through Dec 2025, up 127.94% year-over-year, with the annual reading at $27.4 million for FY2025, 127.94% up from the prior year.
  • Notes Payables for Q4 2025 was $27.4 million at Jaguar Health, up from $23.1 million in the prior quarter.
  • The five-year high for Notes Payables was $27.4 million in Q4 2025, with the low at $1.1 million in Q2 2021.
  • Average Notes Payables over 5 years is $11.0 million, with a median of $11.3 million recorded in 2024.
  • The sharpest move saw Notes Payables crashed 87.22% in 2021, then surged 594.59% in 2022.
  • Over 5 years, Notes Payables stood at $3.2 million in 2021, then surged by 398.84% to $15.9 million in 2022, then tumbled by 69.36% to $4.9 million in 2023, then soared by 147.34% to $12.0 million in 2024, then soared by 127.94% to $27.4 million in 2025.
  • According to Business Quant data, Notes Payables over the past three periods came in at $27.4 million, $23.1 million, and $18.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.